Argenx Surges As Amgen Struggles To Take On 'The King'
The Relative Strength (RS) Rating for Bicara Therapeutics (BCAX) jumped into a new percentile Thursday, with a rise from 75 to 83. ↑ X NOW PLAYING How To Trade Options: Choosing The Right Strategy For Best Results IBD's unique RS Rating tracks market …